Colorectal cancer (original) (raw)

• Kuipers, E. J., Rösch, T. & Bretthauer, M. Colorectal cancer screening — optimizing current strategies and new directions. Nat. Rev. Clin. Oncol. 10, 130–142 (2013). A review of the current state of the art of colorectal cancer screening.
  Article CAS PubMed Google Scholar
• Warthin, A. S. Heredity with reference to carcinoma: as shown by the study of the cases examined in the pathological laboratory of the University of Michigan. Arch. Intern. Med. 12, 546–555 (1913).
  Article Google Scholar
• Capelle, L. G. et al. Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. Gastroenterology 138, 487–492 (2010).
  Article PubMed Google Scholar
• Vasen, H. F. A., Tomlinson, I. & Castells, A. Clinical management of hereditary colorectal cancer syndromes. Nat. Rev. Gastroenterol. Hepatol. 12, 88–97 (2015).
  Article PubMed Google Scholar
• Papamichael, D. et al. Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013. Ann. Oncol. 26, 463–476 (2014).
  Article PubMed Google Scholar
• Hurwitz, H. et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N. Engl. J. Med. 350, 2335–2342 (2004).
  Article CAS PubMed Google Scholar
• Heemskerk-Gerritsen, B. A. M. et al. Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis. Int. J. Cancer 136, 668–677 (2015).
  CAS PubMed Google Scholar
• De Jonge, V. et al. Quality evaluation of colonoscopy reporting and colonoscopy performance in daily clinical practice. Gastrointest. Endosc. 75, 98–106 (2012).
  Article PubMed Google Scholar
• Valori, R. et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition — quality assurance in endoscopy in colorectal cancer screening and diagnosis. Endoscopy 44, SE88–SE105 (2012). This paper describes the results of extensive international consensus on quality-assurance measures for colorectal cancer screening.
  Article PubMed Google Scholar
• GLOBOCAN. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. GLOBOCAN[online], (2015).
• Rohani-Rasaf, M., Abdollahi, M., Jazayeri, S., Kalantari, N. & Asadi-Lari, M. Correlation of cancer incidence with diet, smoking and socio-economic position across 22 districts of Tehran in 2008. Asian Pac. J. Cancer Prev. 14, 1669–1676 (2013).
  Article PubMed Google Scholar
• Draft, C. et al. Global, regional and national levels of age-specific mortality and 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385, 1990–2013 (2015).
  Google Scholar
• Tiwari, A. K., Roy, H. K. & Lynch, H. T. Lynch syndrome in the 21st century: clinical perspectives. QJM http://dx.doi.org/10.1093/qjmed/hcv137 (2015).
• Pérez-Carbonell, L. et al. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer. Gut 61, 865–872 (2012).
  Article CAS PubMed Google Scholar
• Van Lier, M. G. F. et al. Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome. J. Pathol. 226, 764–774 (2012).
  Article CAS PubMed Google Scholar
• Jess, T., Rungoe, C. & Peyrin-Biroulet, L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin. Gastroenterol. Hepatol. 10, 639–645 (2012).
  Article PubMed Google Scholar
• Jess, T. et al. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology 143, 375–381.e1 (2012).
  Article PubMed Google Scholar
• Castaño-Milla, C., Chaparro, M. & Gisbert, J. P. Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis. Aliment. Pharmacol. Ther. 39, 645–659 (2014).
  Article PubMed Google Scholar
• Herrinton, L. J. et al. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology 143, 382–389 (2012).
  Article PubMed Google Scholar
• World Cancer Research Fund/American Institute for Cancer Research. Continuous update project report. Food, nutrition, physical activity, and the prevention of colorectal cancer. Diet and Cancer Report [online], (2011).
• Guraya, S. Y. Association of type 2 diabetes mellitus and the risk of colorectal cancer: a meta-analysis and systematic review. World J. Gastroenterol. 21, 6026–6031 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Fedirko, V. et al. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann. Oncol. 22, 1958–1972 (2011).
  Article CAS PubMed Google Scholar
• Liang, P. S., Chen, T.-Y. & Giovannucci, E. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int. J. Cancer 124, 2406–2415 (2009).
  Article CAS PubMed Google Scholar
• Botteri, E. et al. Smoking and colorectal cancer: a meta-analysis. JAMA 300, 2765–2778 (2008).
  Article CAS PubMed Google Scholar
• Song, M., Garrett, W. S. & Chan, A. T. Nutrients, foods, and colorectal cancer prevention. Gastroenterology 148, 1244–1260.e16 (2015). An extensive review of the current knowledge on nutrients and colorectal cancer risk as well as prevention.
  Article CAS PubMed Google Scholar
• Dahm, C. C. et al. Dietary fiber and colorectal cancer risk: a nested case–control study using food diaries. 102, 614–626 (2010).
• Arem, H. et al. Physical activity and cancer-specific mortality in the NIH-AARP Diet and Health Study cohort. Int. J. Cancer 135, 423–431 (2014).
  Article CAS PubMed Google Scholar
• Algra, A. M. & Rothwell, P. M. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol. 13, 518–527 (2012).
  Article CAS PubMed Google Scholar
• Doubeni, C. A. et al. Contribution of behavioral risk factors and obesity to socioeconomic differences in colorectal cancer incidence. J. Natl Cancer Inst. 104, 1353–1362 (2012).
  Article PubMed PubMed Central Google Scholar
• Erdrich, J., Zhang, X., Giovannucci, E. & Willett, W. Proportion of colon cancer attributable to lifestyle in a cohort of US women. Cancer Causes Control 26, 1271–1279 (2015).
  Article PubMed PubMed Central Google Scholar
• Platz, E. A. et al. Proportion of colon cancer risk that might be preventable in a cohort of middle-aged US men. Cancer Causes Control 11, 579–588 (2000).
  Article CAS PubMed Google Scholar
• Aleksandrova, K. et al. Combined impact of healthy lifestyle factors on colorectal cancer: a large European cohort study. BMC Med. 12, 168 (2014).
  Article PubMed PubMed Central Google Scholar
• Andersen, V. & Vogel, U. Systematic review: interactions between aspirin, and other nonsteroidal anti-inflammatory drugs, and polymorphisms in relation to colorectal cancer. Aliment. Pharmacol. Ther. 40, 147–159 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Nan, H. et al. Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants. JAMA 313, 1133–1142 (2015). A large study combining data from multiple case–control and cohort studies looking at the preventive effect of aspirin and NSAID use on the risk of colorectal cancer.
  Article CAS PubMed PubMed Central Google Scholar
• Bardou, M., Barkun, A. & Martel, M. Effect of statin therapy on colorectal cancer. Gut 59, 1572–1585 (2010). A review on the preventive effects of statin therapy on the development of colorectal cancer.
  Article CAS PubMed Google Scholar
• Liu, Y. et al. Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies. Cancer Causes Control 25, 237–249 (2014).
  Article CAS PubMed Google Scholar
• Limsui, D. et al. Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older women. Gut 61, 1299–1305 (2012).
  Article CAS PubMed Google Scholar
• Ogino, S., Chan, A. T., Fuchs, C. S. & Giovannucci, E. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 60, 397–411 (2011).
  Article PubMed Google Scholar
• Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57–70 (2000).
  Article CAS PubMed Google Scholar
• Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).
  Article CAS PubMed Google Scholar
• Colussi, D., Brandi, G., Bazzoli, F. & Ricciardiello, L. Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int. J. Mol. Sci. 14, 16365–16385 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Grady, W. M. & Carethers, J. M. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 135, 1079–1099 (2008).
  Article CAS PubMed Google Scholar
• Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759–767 (1990).
  Article CAS PubMed Google Scholar
• Lengauer, C., Kinzler, K. W. & Vogelstein, B. Genetic instabilities in human cancers. Nature 396, 643–649 (1998).
  Article CAS PubMed Google Scholar
• Kinzler, K. W. & Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 87, 159–170 (1996).
  Article CAS PubMed Google Scholar
• Zeki, S. S., Graham, T. A. & Wright, N. A. Stem cells and their implications for colorectal cancer. Nat. Rev. Gastroenterol. Hepatol. 8, 90–100 (2011).
  Article PubMed Google Scholar
• Jones, S. et al. Comparative lesion sequencing provides insights into tumor evolution. Proc. Natl Acad. Sci. USA 105, 4283–4288 (2008).
  Article PubMed PubMed Central Google Scholar
• Luo, Y. et al. Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology 147, 418–429.e8 (2014).
  Article CAS PubMed Google Scholar
• Van Engeland, M., Derks, S., Smits, K. M., Meijer, G. A. & Herman, J. G. Colorectal cancer epigenetics: complex simplicity. J. Clin. Oncol. 29, 1382–1391 (2011).
  Article PubMed Google Scholar
• Goldstein, N. S. Serrated pathway and APC (conventional)-type colorectal polyps: molecular–morphologic correlations, genetic pathways, and implications for classification. Am. J. Clin. Pathol. 125, 146–153 (2006).
  Article CAS PubMed Google Scholar
• Jass, J. R. Hyperplastic polyps and colorectal cancer: is there a link? Clin. Gastroenterol. Hepatol. 2, 1–8 (2004).
  Article PubMed Google Scholar
• Bettington, M. et al. The serrated pathway to colorectal carcinoma: current concepts and challenges. Histopathology 62, 367–386 (2013).
  Article PubMed Google Scholar
• Rex, D. K. et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am. J. Gastroenterol. 107, 1315–1329 (2012). Expert panel recommendations for the detection and management of serrated colorectal polyps.
  Article PubMed PubMed Central Google Scholar
• Kambara, T. et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 53, 1137–1144 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Noffsinger, A. E. Serrated polyps and colorectal cancer: new pathway to malignancy. Annu. Rev. Pathol. 4, 343–364 (2009).
  Article CAS PubMed Google Scholar
• Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330–337 (2012).
  Article CAS Google Scholar
• Chittenden, T. W. et al. Functional classification analysis of somatically mutated genes in human breast and colorectal cancers. Genomics 91, 508–511 (2008).
  Article CAS PubMed Google Scholar
• Jubb, A. M., Bell, S. M. & Quirke, P. Methylation and colorectal cancer. J. Pathol. 195, 111–134 (2001).
  Article CAS PubMed Google Scholar
• Starr, T. K. et al. A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science 323, 1747–1750 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Parsons, D. W. et al. Colorectal cancer: mutations in a signalling pathway. Nature 436, 792 (2005).
  Article CAS PubMed Google Scholar
• Brennan, C. W. et al. The somatic genomic landscape of glioblastoma. Cell 155, 462–477 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Grady, W. M. & Pritchard, C. C. Molecular alterations and biomarkers in colorectal cancer. Toxicol. Pathol. 42, 124–139 (2014). A review on the molecular pathways that lead to colorectal cancer.
  Article CAS PubMed Google Scholar
• Bardelli, A. et al. Mutational analysis of the tyrosine kinome in colorectal cancers. Science 300, 949 (2003).
  Article CAS PubMed Google Scholar
• Lao, V. V. & Grady, W. M. Epigenetics and colorectal cancer. Nat. Rev. Gastroenterol. Hepatol. 8, 686–700 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Kim, Y.-H. et al. CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer. Genes Chromosomes Cancer 45, 781–789 (2006).
  Article CAS PubMed Google Scholar
• Bird, A. The essentials of DNA methylation. Cell 70, 5–8 (1992).
  Article CAS PubMed Google Scholar
• Worthley, D. L. et al. DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer. Oncogene 29, 1653–1662 (2010).
  Article CAS PubMed Google Scholar
• Yamauchi, M. et al. Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut 61, 847–854 (2012). A study showing the correlation between the molecular features of colorectal cancer and the location of the tumour.
  Article CAS PubMed Google Scholar
• Rosty, C. et al. PIK3CA activating mutation in colorectal carcinoma: associations with molecular features and survival. PLoS ONE 8, e65479 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Galon, J. et al. Towards the introduction of the “Immunoscore” in the classification of malignant tumours. J. Pathol. 232, 199–209 (2014).
  Article CAS PubMed Google Scholar
• Kostic, A. D. et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22, 292–298 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Tahara, T. et al. Fusobacterium in colonic flora and molecular features of colorectal carcinoma. Cancer Res. 74, 1311–1318 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Mima, K. et al. Fusobacterium nucleatum and T cells in colorectal carcinoma. JAMA Oncol. 1, E1–E9 (2015).
  Article Google Scholar
• Morris, E. J. A., Rutter, M. D., Finan, P. J., Thomas, J. D. & Valori, R. Post-colonoscopy colorectal cancer (PCCRC) rates vary considerably depending on the method used to calculate them: a retrospective observational population-based study of PCCRC in the English National Health Service. Gut 64, 1248–1256 (2014).
  Article PubMed Google Scholar
• Kaminski, M. F. et al. Quality indicators for colonoscopy and the risk of interval cancer. N. Engl. J. Med. 362, 1795–1803 (2010). The first study to show that the risk of post-colonoscopy cancer is higher when the colonoscopy was performed by an endoscopist with low adenoma detection rates.
  Article CAS PubMed Google Scholar
• Zauber, A. G. et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N. Engl. J. Med. 366, 687–696 (2012). This study is a long-term follow-up of the National Polyp Study, showing persistently lower mortality of colorectal cancer after colonoscopy with adenoma removal.
  Article CAS PubMed PubMed Central Google Scholar
• Pox, C. P. et al. Efficacy of a nationwide screening colonoscopy program for colorectal cancer. Gastroenterology 142, 1460–1467.e2 (2012).
  Article PubMed Google Scholar
• Winawer, S. J. et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N. Engl. J. Med. 329, 1977–1981 (1993).
  Article CAS PubMed Google Scholar
• Nishihara, R. et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N. Engl. J. Med. 369, 1095–1105 (2013).
  Article CAS PubMed Google Scholar
• Corley, D. A. et al. Adenoma detection rate and risk of colorectal cancer and death. N. Engl. J. Med. 370, 1298–1306 (2014). This paper provides important confirmation that the risk of colorectal cancer and death with long-term follow-up after colonoscopy relates to adenoma detection rates.
  Article CAS PubMed PubMed Central Google Scholar
• Sanduleanu, S. et al. Definition and taxonomy of interval colorectal cancers: a proposal for standardising nomenclature. Gut 64, 1257–1267 (2015).
  Article CAS PubMed Google Scholar
• Nagorni, A., Bjelakovic, G. & Petrovic, B. Narrow band imaging versus conventional white light colonoscopy for the detection of colorectal polyps. Cochrane Database Syst. Rev. 1, CD008361 (2012).
  PubMed Google Scholar
• Pohl, J. et al. Pancolonic chromoendoscopy with indigo carmine versus standard colonoscopy for detection of neoplastic lesions: a randomised two-centre trial. Gut 60, 485–490 (2010).
  Article PubMed Google Scholar
• Waye, J. D. et al. A retrograde-viewing device improves detection of adenomas in the colon: a prospective efficacy evaluation (with videos). Gastrointest. Endosc. 71, 551–556 (2010).
  Article PubMed Google Scholar
• Leufkens, A. M. et al. Effect of a retrograde-viewing device on adenoma detection rate during colonoscopy: the TERRACE study. Gastrointest. Endosc. 73, 480–489 (2011).
  Article PubMed Google Scholar
• DeMarco, D. C. et al. Impact of experience with a retrograde-viewing device on adenoma detection rates and withdrawal times during colonoscopy: the Third Eye Retroscope Study Group. Gastrointest. Endosc. 71, 542–550 (2010).
  Article PubMed Google Scholar
• Van Gossum, A. et al. Capsule endoscopy versus colonoscopy for the detection of polyps and cancer. N. Engl. J. Med. 361, 264–270 (2009).
  Article CAS PubMed Google Scholar
• Spada, C. et al. Second-generation colon capsule endoscopy compared with colonoscopy. Gastrointest. Endosc. 74, 581–589.e1 (2011).
  Article PubMed Google Scholar
• Spada, C. et al. Meta-analysis shows colon capsule endoscopy is effective in detecting colorectal polyps. Clin. Gastroenterol. Hepatol. 8, 516–522.e8 (2010).
  Article PubMed Google Scholar
• Spada, C. et al. Colon capsule endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 44, 527–536 (2012).
  Article CAS PubMed Google Scholar
• Rex, D. K. et al. Accuracy of capsule colonoscopy in detecting colorectal polyps in a screening population. Gastroenterology 148, 948–957.e2 (2015).
  Article PubMed Google Scholar
• Sung, J. J. Y. et al. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut 64, 121–132 (2014).
  Article PubMed Google Scholar
• Kim, D. H. et al. CT colonography versus colonoscopy for the detection of advanced neoplasia. N. Engl. J. Med. 357, 1403–1412 (2007).
  Article CAS PubMed Google Scholar
• Pickhardt, P. J., Hassan, C., Halligan, S. & Marmo, R. Colorectal cancer: CT colonography and colonoscopy for detection — systematic review and meta-analysis. Radiology 259, 393–405 (2011).
  Article PubMed PubMed Central Google Scholar
• Spada, C. et al. Colon capsule versus CT colonography in patients with incomplete colonoscopy: a prospective, comparative trial. Gut 64, 272–281 (2015).
  Article PubMed Google Scholar
• Park, S. H. et al. CT colonography for detection and characterisation of synchronous proximal colonic lesions in patients with stenosing colorectal cancer. Gut 61, 1716–1722 (2012).
  Article PubMed Google Scholar
• Plumb, A. A. et al. CT colonography in the English Bowel Cancer Screening Programme: national survey of current practice. Clin. Radiol. 68, 479–487 (2013).
  Article CAS PubMed Google Scholar
• De Wijkerslooth, T. R. et al. Burden of colonoscopy compared to non-cathartic CT-colonography in a colorectal cancer screening programme: randomised controlled trial. Gut 61, 1552–1559 (2012).
  Article PubMed Google Scholar
• De Haan, M. C., van Gelder, R. E., Graser, A., Bipat, S. & Stoker, J. Diagnostic value of CT-colonography as compared to colonoscopy in an asymptomatic screening population: a meta-analysis. Eur. Radiol. 21, 1747–1763 (2011).
  Article PubMed PubMed Central Google Scholar
• Pooler, B. D., Kim, D. H., Lam, V. P., Burnside, E. S. & Pickhardt, P. J. CT Colonography Reporting and Data System (C-RADS): benchmark values from a clinical screening program. Am. J. Roentgenol. 202, 1232–1237 (2014).
  Article Google Scholar
• Stoop, E. M. et al. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol. 13, 55–64 (2012).
  Article PubMed Google Scholar
• Yee, J. et al. ACR Appropriateness Criteria colorectal cancer screening. J. Am. Coll. Radiol. 11, 543–551 (2014).
  Article PubMed Google Scholar
• Spada, C. et al. Clinical indications for computed tomographic colonography: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Guideline. Endoscopy 46, 897–915 (2014).
  Article PubMed Google Scholar
• Grützmann, R. et al. Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS ONE 3, e3759 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Church, T. R. et al. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut 63, 317–325 (2014).
  Article CAS PubMed Google Scholar
• Ahlquist, D. A. et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann. Intern. Med. 149, 441–450 (2008).
  Article PubMed PubMed Central Google Scholar
• Imperiale, T. F. et al. Multitarget stool DNA testing for colorectal-cancer screening. N. Engl. J. Med. 370, 1287–1297 (2014).
  Article CAS PubMed Google Scholar
• Bosch, L. J. W. et al. Molecular tests for colorectal cancer screening. Clin. Colorectal Cancer 10, 8–23 (2011).
  Article CAS PubMed Google Scholar
• Kuipers, E. J. Colorectal cancer: screening — one small step for mankind, one giant leap for man. Nat. Rev. Clin. Oncol. 11, 5–6 (2014).
  Article PubMed Google Scholar
• Brenner, H., Altenhofen, L., Stock, C. & Hoffmeister, M. Natural history of colorectal adenomas: birth cohort analysis among 3.6 million participants of screening colonoscopy. Cancer Epidemiol. Biomarkers Prev. 22, 1043–1051 (2013).
  Article PubMed Google Scholar
• Schreuders, E. H. et al. Colorectal cancer screening: a global overview of existing programmes. Gut 64, 1637–1649 (2015). A review of existing colorectal cancer programmes worldwide.
  Article PubMed Google Scholar
• Singh, H. et al. The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology 139, 1128–1137 (2010).
  Article PubMed Google Scholar
• Brenner, H., Stock, C. & Hoffmeister, M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. Br. Med. J. 2467, 1–12 (2014). A systematic review on the long-term effect of sigmoidoscopy and colonoscopy on colorectal cancer incidence and mortality.
  Google Scholar
• Le Clercq, C. M. C. et al. Metachronous colorectal cancers result from missed lesions and non-compliance with surveillance. Gastrointest. Endosc. 82, 325–333.e2 (2015).
  Article PubMed Google Scholar
• Hoff, G., Grotmol, T., Skovlund, E. & Bretthauer, M. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ 338, b1846 (2009).
  Article PubMed PubMed Central Google Scholar
• Atkin, W. S. et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 375, 1624–1633 (2010).
  Article PubMed Google Scholar
• Segnan, N. et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial — SCORE. J. Natl Cancer Inst. 103, 1310–1322 (2011).
  Article PubMed Google Scholar
• Van Putten, P. G. et al. Nurse endoscopists perform colonoscopies according to the international standard and with high patient satisfaction. Endoscopy 44, 1127–1132 (2012).
  Article CAS PubMed Google Scholar
• Stephens, M. et al. Non-physician endoscopists: a systematic review. World J. Gastroenterol. 21, 5056–5071 (2015).
  Article PubMed PubMed Central Google Scholar
• Lansdorp-Vogelaar, I., van Ballegooijen, M., Zauber, A. G., Habbema, J. D. F. & Kuipers, E. J. Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. J. Natl Cancer Inst. 101, 1412–1422 (2009).
  Article PubMed PubMed Central Google Scholar
• Inadomi, J. M. et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch. Intern. Med. 172, 575–582 (2012).
  Article PubMed PubMed Central Google Scholar
• Van Dam, L., Kuipers, E. J., Steyerberg, E. W., van Leerdam, M. E. & de Beaufort, I. D. The price of autonomy: should we offer individuals a choice of colorectal cancer screening strategies? Lancet Oncol. 14, e38–e46 (2013).
  Article PubMed Google Scholar
• Hol, L. et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 59, 62–68 (2009).
  Article Google Scholar
• Van Rossum, L. G. et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 135, 82–90 (2008).
  Article PubMed Google Scholar
• Wilschut, J. A. et al. Fecal occult blood testing when colonoscopy capacity is limited. J. Natl Cancer Inst. 103, 1741–1751 (2011).
  Article PubMed Google Scholar
• Quintero, E. et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N. Engl. J. Med. 366, 697–706 (2012).
  Article CAS PubMed Google Scholar
• Kapidzic, A. et al. Attendance and yield over three rounds of population-based fecal immunochemical test screening. Am. J. Gastroenterol. 109, 1257–1264 (2014).
  Article PubMed Google Scholar
• Van Roon, A. H. C. et al. Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance. Clin. Gastroenterol. Hepatol. 9, 333–339 (2011).
  Article PubMed Google Scholar
• Goede, S. L. et al. Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening. Gut 62, 727–734 (2012).
  Article PubMed Google Scholar
• Van Roon, A. H. C. et al. Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening. Gut 62, 409–415 (2012).
  Article PubMed Google Scholar
• Hol, L. et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br. J. Cancer 100, 1103–1110 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Van Heijningen, E. M. B. et al. Features of adenoma and colonoscopy associated with recurrent colorectal neoplasia based on a large community-based study. Gastroenterology 144, 1410–1418 (2013).
  Article PubMed Google Scholar
• Lieberman, D. A. et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 143, 844–857 (2012).
  Article PubMed Google Scholar
• Martínez, M. E. et al. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology 136, 832–841 (2009).
  Article PubMed Google Scholar
• Løberg, M. et al. Long-term colorectal-cancer mortality after adenoma removal. N. Engl. J. Med. 371, 799–807 (2014).
  Article CAS PubMed Google Scholar
• Hassan, C. et al. Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 45, 842–851 (2013).
  Article PubMed Google Scholar
• Cairns, S. R. et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups. Gut 59, 666–689 (2010).
  Article PubMed Google Scholar
• Lieberman, D. A. et al. Low rate of large polyps (>9 mm) within 10 years after an adequate baseline colonoscopy with no polyps. Gastroenterology 147, 343–350 (2014).
  Article PubMed Google Scholar
• Lansdorp-Vogelaar, I. et al. Personalizing age of cancer screening cessation based on comorbid conditions: Model estimates of harms and benefits. Ann. Intern. Med. 161, 104–112 (2014).
  Article PubMed PubMed Central Google Scholar
• van Hees, F. et al. Should colorectal cancer screening be considered in elderly persons without previous screening? Ann. Intern. Med. 160, 750–759 (2014).
  Article PubMed PubMed Central Google Scholar
• Hazewinkel, Y. et al. Prevalence of serrated polyps and association with synchronous advanced neoplasia in screening colonoscopy. Endoscopy 46, 219–224 (2014).
  PubMed Google Scholar
• IJspeert, J. E. G. et al. Development and validation of the WASP classification system for optical diagnosis of adenomas, hyperplastic polyps and sessile serrated adenomas/polyps. Gut http://dx.doi.org/10.1136/gutjnl-2014-308411 (2015).
• Jeffery, G. M., Hickey, B. E. & Hider, P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst. Rev. 1, CD002200 (2002).
  Google Scholar
• Primrose, J. N. et al. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA 311, 263–270 (2014).
  Article CAS PubMed Google Scholar
• Brenner, H. et al. Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study. Int. J. Cancer 131, 1649–1658 (2012).
  Article CAS PubMed Google Scholar
• Breugom, A. J. et al. Quality assurance in the treatment of colorectal cancer: the EURECCA initiative. Ann. Oncol. 25, 1485–1492 (2014).
  Article CAS PubMed Google Scholar
• Van de Velde, C. J. H. et al. EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum. Eur. J. Cancer 50,1.e1–1.e34 (2014).
  Article Google Scholar
• Van de Velde, C. J. H. et al. Experts reviews of the multidisciplinary consensus conference colon and rectal cancer 2012: science, opinions and experiences from the experts of surgery. Eur. J. Surg. Oncol. 40, 454–468 (2014). A review of the EURECCA consensus on colorectal cancer surgery.
  Article CAS PubMed Google Scholar
• Quirke, P., West, N. P. & Nagtegaal, I. D. EURECCA consensus conference highlights about colorectal cancer clinical management: the pathologists expert review. Virchows Arch. 464, 129–134 (2014).
  Article CAS PubMed Google Scholar
• Valentini, V. et al. EURECCA consensus conference highlights about rectal cancer clinical management: the radiation oncologist's expert review. Radiother. Oncol. 110, 195–198 (2014).
  Article PubMed Google Scholar
• Tudyka, V. et al. EURECCA consensus conference highlights about colon and rectal cancer multidisciplinary management: the radiology experts review. Eur. J. Surg. Oncol. 40, 469–475 (2014).
  Article CAS PubMed Google Scholar
• Van de Velde, C. J. H. et al. EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe. Eur. J. Cancer 49, 2784–2790 (2013).
  Article PubMed Google Scholar
• Rutten, H. J. T., den Dulk, M., Lemmens, V. E., van de Velde, C. J. H. & Marijnen, C. A. M. Controversies of total mesorectal excision for rectal cancer in elderly patients. Lancet Oncol. 9, 494–501 (2008).
  Article PubMed Google Scholar
• Gooiker, G. A. et al. Risk factors for excess mortality in the first year after curative surgery for colorectal cancer. Ann. Surg. Oncol. 19, 2428–2434 (2012).
  Article PubMed PubMed Central Google Scholar
• Van den Broek, C. B. M. et al. The survival gap between middle-aged and elderly colon cancer patients. Time trends in treatment and survival. Eur. J. Surg. Oncol. 37, 904–912 (2011).
  Article CAS PubMed Google Scholar
• Dekker, J. W. T. et al. Cause of death the first year after curative colorectal cancer surgery; a prolonged impact of the surgery in elderly colorectal cancer patients. Eur. J. Surg. Oncol. 40, 1481–1487 (2014).
  Article CAS PubMed Google Scholar
• Mulder, S. A. et al. Prevalence and prognosis of synchronous colorectal cancer: a Dutch population-based study. Cancer Epidemiol. 35, 442–447 (2011).
  Article PubMed Google Scholar
• Taylor, F. G. M. et al. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study. J. Clin. Oncol. 32, 34–43 (2014).
  Article PubMed Google Scholar
• Veldkamp, R. et al. Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. Lancet Oncol. 6, 477–484 (2005).
  Article PubMed Google Scholar
• Bonjer, H. J. et al. A randomized trial of laparoscopic versus open surgery for rectal cancer. N. Engl. J. Med. 372, 1324–1332 (2015). A randomized trial with long-term follow-up, showing similar results for open and laparoscopic rectal cancer surgery.
  Article CAS PubMed Google Scholar
• Colon Cancer Laparoscopic or Open Resection Study Group et al. Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol. 10, 44–52 (2009).
  Article CAS PubMed Google Scholar
• Chen, J. et al. Meta-analysis of temporary ileostomy versus colostomy for colorectal anastomoses. Acta Chir. Belg. 113, 330–339 (2013).
  Article CAS PubMed Google Scholar
• Van Hooft, J. E. et al. Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy 46, 990–1053 (2014).
  Article PubMed Google Scholar
• Fiori, E. et al. Palliative management for patients with subacute obstruction and stage IV unresectable rectosigmoid cancer: colostomy versus endoscopic stenting: final results of a prospective randomized trial. Am. J. Surg. 204, 321–326 (2012).
  Article PubMed Google Scholar
• De Graaf, E. J. R. et al. Transanal endoscopic microsurgery versus total mesorectal excision of T1 rectal adenocarcinomas with curative intention. Eur. J. Surg. Oncol. 35, 1280–1285 (2009).
  Article CAS PubMed Google Scholar
• Doornebosch, P. G. et al. Transanal endoscopic microsurgery for T1 rectal cancer: size matters! Surg. Endosc. 26, 551–557 (2011).
  Article PubMed Google Scholar
• Lezoche, E. et al. Randomized clinical trial of endoluminal locoregional resection versus laparoscopic total mesorectal excision for T2 rectal cancer after neoadjuvant therapy. Br. J. Surg. 99, 1211–1218 (2012).
  Article CAS PubMed Google Scholar
• Martin-Perez, B., Andrade-Ribeiro, G. D., Hunter, L. & Atallah, S. A systematic review of transanal minimally invasive surgery (TAMIS) from 2010 to 2013. Tech. Coloproctol. 18, 775–788 (2014).
  Article CAS PubMed Google Scholar
• Nagtegaal, I. D., Marijnen, C. A. M., Kranenbarg, E. K., van de Velde, C. J. H. & van Krieken, J. H. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am. J. Surg. Pathol. 26, 350–357 (2002).
  Article PubMed Google Scholar
• Quirke, P. et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 373, 821–828 (2009).
  Article PubMed PubMed Central Google Scholar
• Heald, R. J., Husband, E. M. & Ryall, R. D. The mesorectum in rectal cancer surgery — the clue to pelvic recurrence? Br. J. Surg. 69, 613–616 (1982).
  Article CAS PubMed Google Scholar
• Ramji, K. M. et al. Comparison of clinical and economic outcomes between robotic, laparoscopic, and open rectal cancer surgery: early experience at a tertiary care center. Surg. Endosc. http://dx.doi.org/10.1007/s00464-015-4390-8 (2015).
• Kapiteijn, E. et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N. Engl. J. Med. 345, 638–646 (2001).
  Article CAS PubMed Google Scholar
• Folkesson, J. et al. Swedish rectal cancer trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J. Clin. Oncol. 23, 5644–5650 (2005).
  Article PubMed Google Scholar
• Sebag-Montefiore, D. et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373, 811–820 (2009).
  Article PubMed PubMed Central Google Scholar
• Van Gijn, W. et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 12, 575–582 (2011). A randomized trial showing that preoperative radiotherapy reduces local recurrence rates after TME surgery.
  Article PubMed Google Scholar
• Pettersson, D. et al. Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Br. J. Surg. 97, 580–587 (2010).
  Article CAS PubMed Google Scholar
• Juul, T. et al. Low anterior resection syndrome and quality of life. Dis. Colon Rectum 57, 585–591 (2014).
  Article PubMed Google Scholar
• García, M. et al. Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer. BMC Cancer 15, 59 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br. J. Surg. 100, E1–E33 (2013).
  Article Google Scholar
• Habr-Gama, A., Perez, R. O., São Julião, G. P., Proscurshim, I. & Gama-Rodrigues, J. Nonoperative approaches to rectal cancer: a critical evaluation. Semin. Radiat. Oncol. 21, 234–239 (2011).
  Article PubMed Google Scholar
• Maas, M. et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J. Clin. Oncol. 29, 4633–4640 (2011).
  Article PubMed Google Scholar
• Dalton, R. S. J. et al. A single-centre experience of chemoradiotherapy for rectal cancer: is there potential for nonoperative management? Colorectal Dis. 14, 567–571 (2012).
  Article CAS PubMed Google Scholar
• Fujita, S. et al. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Lancet Oncol. 13, 616–621 (2012).
  Article PubMed Google Scholar
• Påhlman, L. et al. The Swedish rectal cancer registry. Br. J. Surg. 94, 1285–1292 (2007).
  Article PubMed Google Scholar
• Wibe, A. et al. Effect of hospital caseload on long-term outcome after standardization of rectal cancer surgery at a national level. Br. J. Surg. 92, 217–224 (2005).
  Article CAS PubMed Google Scholar
• Birkmeyer, J. D. et al. Hospital volume and surgical mortality in the United States. N. Engl. J. Med. 346, 1128–1137 (2002).
  Article PubMed Google Scholar
• Kehlet, H. Multimodal approach to control postoperative pathophysiology and rehabilitation. Br. J. Anaesth. 78, 606–617 (1997).
  Article CAS PubMed Google Scholar
• Kehlet, H. & Mogensen, T. Hospital stay of 2 days after open sigmoidectomy with a multimodal rehabilitation programme. Br. J. Surg. 86, 227–230 (1999).
  Article CAS PubMed Google Scholar
• Lassen, K. et al. Consensus review of optimal perioperative care in colorectal surgery: Enhanced Recovery After Surgery (ERAS) Group recommendations. Arch. Surg. 144, 961–969 (2009).
  Article PubMed Google Scholar
• Boelens, P. G. et al. Reduction of postoperative ileus by early enteral nutrition in patients undergoing major rectal surgery. Ann. Surg. 259, 649–655 (2014).
  Article PubMed Google Scholar
• Sauer, R. et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N. Engl. J. Med. 351, 1731–1740 (2004).
  Article CAS PubMed Google Scholar
• Glimelius, B., Tiret, E., Cervantes, A. & Arnold, D. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 24, vi81–vi88 (2013).
  Article PubMed Google Scholar
• Labianca, R. et al. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 24, vi64–vi72 (2013).
  Article PubMed Google Scholar
• McCleary, N. J. et al. Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT database. J. Clin. Oncol. 31, 2600–2606 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Van Cutsem, E., Cervantes, A., Nordlinger, B. & Arnold, D. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 25, iii1–iii9 (2014). European Society of Medical Oncology guidelines for the management of metastatic colorectal cancer.
  Article PubMed Google Scholar
• Amado, R. G. et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J. Clin. Oncol. 26, 1626–1634 (2008).
  Article CAS PubMed Google Scholar
• Douillard, J.-Y. et al. Panitumumab–FOLFOX4 treatment and RAS mutations in colorectal cancer. N. Engl. J. Med. 369, 1023–1034 (2013).
  Article CAS PubMed Google Scholar
• Ferrara, N., Hillan, K. J., Gerber, H.-P. & Novotny, W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat. Rev. Drug Discov. 3, 391–400 (2004).
  Article CAS PubMed Google Scholar
• Willett, C. G. et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat. Med. 10, 145–147 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Giantonio, B. J. et al. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J. Clin. Oncol. 25, 1539–1544 (2007).
  Article CAS PubMed Google Scholar
• Kubicka, S. et al. Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings. Ann. Oncol. 24, 2342–2349 (2013).
  Article CAS PubMed Google Scholar
• Van Cutsem, E. et al. Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a Phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen. J. Clin. Oncol. 30, 3499–3506 (2012).
  Article CAS PubMed Google Scholar
• Tomlinson, J. S. et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J. Clin. Oncol. 25, 4575–4580 (2007).
  Article PubMed Google Scholar
• Evrard, S. et al. Combined ablation and resection (CARe) as an effective parenchymal sparing treatment for extensive colorectal liver metastases. PLoS ONE 9, e114404 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Ayez, N. et al. Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy. Ann. Surg. Oncol. 19, 1618–1627 (2012).
  Article PubMed Google Scholar
• Falcone, A. et al. Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. J. Clin. Oncol. 25, 1670–1676 (2007).
  Article CAS PubMed Google Scholar
• Heinemann, V. et al. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial. Lancet Oncol. 15, 1065–1075 (2014).
  Article CAS PubMed Google Scholar
• Benoist, S. et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J. Clin. Oncol. 24, 3939–3945 (2006).
  Article PubMed Google Scholar
• Simkens, L. H. J., Koopman, M. & Punt, C. J. A. Optimal duration of systemic treatment in metastatic colorectal cancer. Curr. Opin. Oncol. 26, 448–453 (2014).
  Article CAS PubMed Google Scholar
• Grothey, A. et al. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet 381, 303–312 (2013).
  Article CAS PubMed Google Scholar
• Smith, J. J. & Weiser, M. R. Outcomes in non-metastatic colorectal cancer. J. Surg. Oncol. 110, 518–526 (2014).
  Article PubMed Google Scholar
• Juul, T. et al. International validation of the low anterior resection syndrome score. Ann. Surg. 259, 728–734 (2014).
  Article PubMed Google Scholar
• Feddern, M.-L., Jensen, T. S. & Laurberg, S. Chronic pain in the pelvic area or lower extremities after rectal cancer treatment and its impact on quality of life: a population-based cross-sectional study. Pain 156, 1765–1771 (2015).
  Article PubMed Google Scholar
• De Caluwé, L., Van Nieuwenhove, Y. & Ceelen, W. P. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. Cochrane Database Syst. Rev. 2, CD006041 (2013).
  Google Scholar
• Bregendahl, S., Emmertsen, K. J., Lindegaard, J. C. & Laurberg, S. Urinary and sexual dysfunction in women after resection with and without preoperative radiotherapy for rectal cancer: a population-based cross-sectional study. Colorectal Dis. 17, 26–37 (2015).
  Article CAS PubMed Google Scholar
• Gilbert, A. et al. Systematic review of radiation therapy toxicity reporting in randomized controlled trials of rectal cancer: a comparison of patient-reported outcomes and clinician toxicity reporting. Int. J. Radiat. Oncol. Biol. Phys. 92, 555–567 (2015).
  Article PubMed Google Scholar
• Diouf, M. et al. Could baseline health-related quality of life (QoL) predict overall survival in metastatic colorectal cancer? The results of the GERCOR OPTIMOX 1 study. Health Qual. Life Outcomes 12, 69 (2014).
  Article PubMed PubMed Central Google Scholar
• Otto, S. J. et al. Association of change in physical activity and body weight with quality of life and mortality in colorectal cancer: a systematic review and meta-analysis. Support. Care Cancer 23, 1237–1250 (2015).
  Article CAS PubMed Google Scholar
• Averyt, J. C. & Nishimoto, P. W. Psychosocial issues in colorectal cancer survivorship: the top ten questions patients may not be asking. J. Gastrointest. Oncol. 5, 395–400 (2014).
  PubMed PubMed Central Google Scholar
• Martínez, M. E. et al. One-year risk for advanced colorectal neoplasia: U. S. versus U. K. risk-stratification guidelines. Ann. Intern. Med. 157, 856–864 (2012).
  Article PubMed PubMed Central Google Scholar
• Gao, W., Gulliford, M., Bennett, M. I., Murtagh, F. E. M. & Higginson, I. J. Managing cancer pain at the end of life with multiple strong opioids: a population-based retrospective cohort study in primary care. PLoS ONE 9, e79266 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Zhong, S. et al. Association between physical activity and mortality in breast cancer: a meta-analysis of cohort studies. Eur. J. Epidemiol. 29, 391–404 (2014).
  Article PubMed Google Scholar
• Davies, R. J., Miller, R. & Coleman, N. Colorectal cancer screening: prospects for molecular stool analysis. Nat. Rev. Cancer 5, 199–209 (2005).
  Article CAS PubMed Google Scholar
• Towler, B. P., Irwig, L., Glasziou, P., Weller, D. & Kewenter, J. Screening for colorectal cancer using the faecal occult blood test, hemoccult. Cochrane Database Syst. Rev. 2, CD001216 (2000).
  Google Scholar
• Brenner, H. & Tao, S. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy. Eur. J. Cancer 49, 3049–3054 (2013).
  Article CAS PubMed Google Scholar
• Schoen, R. E. et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N. Engl. J. Med. 366, 2345–2357 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Brenner, H., Chang-Claude, J., Seiler, C. M., Rickert, A. & Hoffmeister, M. Protection from colorectal cancer after colonoscopy: a population-based, case–control study. Ann. Intern. Med. 154, 22–30 (2011).
  Article PubMed Google Scholar
• Cash, B. D. et al. CT colonography of a medicare-aged population: outcomes observed in an analysis of more than 1400 patients. Am. J. Roentgenol. 199, 27–34 (2012).
  Article Google Scholar